Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06485505 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Isotretinoin Versus Excimer Light an Adjuvant in Treating Onychomycosis

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 23, 2026 (before its estimated July 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Trial status: Not Yet Recruiting to Recruiting
    • Primary completion date: Jul 2024 to Jul 2026
    • Study completion date: Dec 2024 to Dec 2026
    • Start date changed from estimate of Jul 2024 to Jul 12, 2024
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
3 groups of patients with onychomycosis will be recruited. Group A will receive itraconazole alone. Group B will receive itraconazole + low dose isotretinoin and group C will be treated with itraconazole + excimer light sessions.
Trial Details
NCT Number NCT06485505
Lead Sponsor Zagazig University
Conditions
(from sponsor)		 Onychomycosis
Related terms Onychomycosis
Enrollment 36 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov